Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new Sample Collection section was added to outline biospecimen collection as part of the trial protocol, and the page reflects an updated revision (v3.5.4) replacing the previous version.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows an updated ClinicalTrials.gov revision label from v3.5.2 to v3.5.3, indicating a site/application version update rather than any change to the study details.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check46 days agoChange DetectedNew update dates 2026-04-08 and 2026-04-09 were added, and 2026-04-01 and 2026-04-02 were removed. This reflects chronology updates to the study record.SummaryDifference0.1%

- Check53 days agoChange DetectedThe study record shows new update entries for 2026-04-02 and 2026-04-01 and deletions for 2026-03-25 and 2026-03-24.SummaryDifference0.1%

- Check61 days agoChange DetectedAdministrative updates were made to the study record dates, adding 2026-03-25 and 2026-03-24 and removing 2026-03-18 and 2026-03-19.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.